Cytomegalovirus-induced embryopathology: Mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model

BMC Developmental Biology

Volumn 6, Issue , 2006, Pages

  Melnick, Michael ^a   Mocarski, Edward S ^b   Abichaker, George ^a   Huang, Jing ^b   Jaskoll, Tina ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BETA CATENIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYOPATHY; EPITHELIUM; EPITHELIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; MESENCHYME; METAPLASIA; MOUSE; NONHUMAN; ONTOGENY; PATHOGENESIS; PROTEIN LOCALIZATION; SUBMANDIBULAR GLAND; UPREGULATION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE MODEL; EMBRYOLOGY; MESODERM; PATHOLOGY; PREGNANCY; SALIVARY GLAND; TIME; VIROLOGY;

CYTOMEGALOVIRUS;

ANIMALS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; MESODERM; MICE; PREGNANCY; SALIVARY GLANDS; SUBMANDIBULAR GLAND; TIME FACTORS;

EID: 33750029434     PISSN: 1471213X     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-6-42     Document Type: Article

References (91)

1. Farber S, Wolbach SB: Intranuclear and cytoplasmic inclusions ("protozoan-like bodies") in the salivary glands and other organs of infants. Am J Pathol 1932, 8:123-135.
2. Smith MG: Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med 1956, 92:424-430.
3. Weller TH: The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations. I. N Engl J Med 1971, 285:203-214.
4. Weller TH: The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations. II. N Engl J Med 1971, 285:267-274.
5. Davison AJ: Comparative betaherpesvirus genome and virion structure. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis Edited by: Arvin AM, Mocarski ES, Moore P, Whitley R, Yamanishi K, Gampadelli-Fiume G and Roizman B. Cambridge, Cambridge Press; 2006.
6. Azam A-Z, Vial Y, Fawer C-L, Zufferey J, Hohlfeld P: Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001, 97:443-448.
7. Syridou G, Skevaki C, Kafetzis DA: Intrauterine infection with parvovirus B19 and CMV: implication in early and late gestation fetal demise. Expert Rev Anti Infect Ther 2005, 3:651-661.
8. Pass RF: Cytomegalovirus. In Fields Virology Volume 2, Fourth Edition Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B and Straus SE. Philadelphia, Lippincott Williams & Wilkins; 2001:2675-2705.
9. Ornoy A, Diav-Citrin O: Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006, 21:399-409.
10. Elbou Ould MA, Luton D, Yadini M, Pedron B, Aujard Y, Jacqz-Aigrain E, Jacquemard F, Sterkers G: Cellular immune response of fetuses to cytomegalovirus. Pediatr Res 2004, 55:280-286.
11. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S: Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006, 35:216-220.
12. Eskild A, Jenum PA, Bruu AL: Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Acta Obstet Gynecol Scand 2005, 84:1035-1041.
13. Gaytant MA, Rours GI, Steegers EA, Galama JM, Semmekrot BA: Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr 2003, 162:248-253.
14. Griffiths PD, Baboonian C: A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol 1984, 91:307-315.
15. Huang SL: Study of intrauterine cytomegaloviruses infection in pregnant women and fetuses. Zhonghua Fu Chan Ke Za Zhi 1990, 25:337-339.
16. Tamiolakis D, Venizelos I, Lambropoulou M, Kotini A, Barbagadaki S, Nikolaidou S, Boglou P, Papadopoulos N: Human decidual cells activity in women with spontaneous abortions of probable CMV aetiology during the first trimester of gestation. An immunohistochemical study with CMV-associated antigen. Acta Medica (Hradec Kralove) 2004, 47:195-199.
17. Baskar JF, Furnari B, Huang ES: Demonstration of developmental anomalies in mouse fetuses by transfer of murine cytomegalovirus DNA-injected eggs to surrogate mothers. J Infect Dis 1993, 167:1288-1295.
18. Baskar JF, Peacock J, Sulik KK, Huang ES: Early-stage developmental abnormalities induced by murine cytomegalovirus. J Infect Dis 1987, 155:661-666.
19. Baskar JF, Stanat SC, Sulik KK, Huang ES: Murine cytomegalovirus-induced congenital defects and fetal maldevelopment. J Infect Dis 1983, 148:836-843.
20. Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S: Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003, 5:1263-1277.
21. Tsutsui Y: Developmental disorders of the mouse brain induced by murine cytomegalovirus: Animal models for congenital cytomegalovirus infection. Pathol Int 1995, 45:91-102.
22. Jaskoll T, Melnick M: Submandibular gland morphogenesis: stage-specific expression of TGF-alpha/EGF, IGF, TGF-beta, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TGF-beta2, TGF-beta3, and EGF-r null mutations. Anat Rec 1999, 256:252-268.
23. Melnick M, Jaskoll T: Mouse submandibular gland morphogenesis: a paradigm for embryonic signal processing. Crit Rev Oral Biol Med 2000, 11:199-215.
24. Shintaku M, Honda T: Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohistrochemistry. Histopathology 1997, 31:408-411.
25. Capone RB, Ha PK, Westra WH, Pilkington TM, Sciubba JJ, Koch WM, Cummings CW: Oncocytic neoplasms of the parotid gland: a 16-year institutional review. Otolaryngol Head Neck Surg 2002, 126:657-662.
26. Brune W, Menard C, Heesemann J, Koszinowski UH: A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001, 291:303-305.
27. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS: A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 2001, 98:7829-7834.
28. Menard C, Wagner M, Ruzsics Z, Holak K, Brune W, Campbell AE, Koszinowski UH: Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol 2003, 77:5557-5570.
29. McCormick AL, Smith VL, Chow D, Mocarski ES: Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol 2003, 77:631-641.
30. McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS: Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 2003, 316:221-233.
31. McCormick AL, Meiering CD, Smith GB, Mocarski ES: Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol 2005, 79:12205-12217.
32. Smith GB, Mocarski ES: Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol 2005, 79:14923-14932.
33. Andoniou CE, Degli-Esposti MA: Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 2006, 84:99-106.
34. Melnick M, Chen H, Zhou YM, Jaskoll T: Interleukin-6 signaling and embryonic mouse submandibular salivary gland morphogenesis. Cells Tissues Organs 2001, 168(4):233-245.
35. Jaskoll T, Chen H, Denny PC, Denny PA, Melnick M: Mouse submandibular gland mucin: embryo-specific mRNA and protein species. Mech Dev 1998, 74:179-183.
36. Melnick M, Chen H, Zhou Y, Jaskoll T: An alternatively spliced Muc10 glycoprotein ligand for putative L-selectin binding during mouse embryonic submandibular gland morphogenesis. Arch Oral Biol 2001, 46:745-757.
37. Davis MA, Reynolds AB: Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell 2006, 10:21-31.
38. Han S, Sidell N, Roser-Page S, Roman J: Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression. Int J Cancer 2004, 111:322-331.
39. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS: Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310:1504-1510.
40. Speir E, Yu ZX, Ferrans VJ, Huang ES, Epstein SE: Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 1998, 83:210-216.
41. Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE: Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A 2002, 99:3932-3937.
42. Rue CA, Jarvis MA, Knoche AJ, Meyers HL, DeFilippis VR, Hansen SG, Wagner M, Fruh K, Anders DG, Wong SW, Barry PA, Nelson JA: A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 2004, 78:12529-12536.
43. Kashimata M, Sayeed S, Ka A, Onetti-Muda A, Sakagami H, Faraggiana T, Gresik EW: The ERK-1/2 signaling pathway is involved in the stimulation of branching morphogenesis of fetal mouse submandibular glands by EGF. Dev Biol 2000, 220:183-196.
44. Melnick M, Chen H, Zhou Y, Jaskoll T: The functional genomic response of developing embryonic submandibular glands to NF-kappa B inhibition. BMC Dev Biol 2001, 1:15-33.
45. Melnick M, Chen H, Zhou Y, Jaskoll T: Embryonic mouse submandibular salivary gland morphogenesis and the TNF/TNF-R1 signal transduction pathway. Anat Rec 2001, 262:318-330.
46. Koyama N, Kashimata M, Sakashita H, Sakagami H, Gresik EW: EGFstimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland. Dev Dyn 2003, 227:216-226.
47. Jaskoll T, Leo T, Witcher D, Ormestad M, Astorga J, Bringas P Jr, Carlsson P, Melnick M: Sonic hedgehog signaling plays an essential role during embryonic salivary gland epithelial branching morphogenesis. Dev Dyn 2004, 229:722-732.
48. Jaskoll T, Witcher D, Toreno L, Bringas P, Moon AM, Melnick M: FGF8 dose-dependent regulation of embryonic submandibular salivary gland morphogenesis. Dev Biol 2004, 268:457-469.
49. Jaskoll T, Abichaker G, Witcher D, Sala FG, Bellusci S, Hajihosseini MK, Melnick M: FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev Biol 2005, 5:11-22.
50. Raser JM, O'Shea EK: Noise in gene expression: origins, consequences, and control. Science 2005, 309:2010-2013.
51. Jiang HY, Petrovas C, Sonenshein GE: RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J Virol 2002, 76:5737-5747.
52. Wang X, Sonenshein GE: Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J Virol 2005, 79:95-105.
53. Burns WH, Wingard JR, Bender WJ, Saral R: Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirus. J Virol 1981, 39:889-893.
54. Jullien J, Gurdon J: Morphogen gradient interpretation by a regulated trafficking step during ligand-receptor transduction. Genes Dev 2005, 19:2682-2694.
55. Murayama T, Mukaida N, Sadanari H, Yamaguchi N, Khabar KS, Tanaka J, Matsushima K, Mori S, Eizuru Y: The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. Biochem Biophys Res Commun 2000, 279:298-304.
56. Benedict CA, Angulo A, Patterson G, Ha S, Huang H, Messerle M, CF W, Ghazal P: Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 2004, 78:741-750.
57. Wessells NK: Tissue Interactions and Development. Menlo Park, CA, Benjamin/Cummings; 1977.
58. Lagenaur LA, Manning WC, Vieira J, Martens CL, Mocarski ES: Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol 1994, 68:7717-7727.
59. Mocarski ES Jr, Courcelle CT: Cytomegaloviruses and their replication. In Fields Virology Volume 2 Fourth Edition Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B and Straus SE. Philadelphia, Lippincott Williams & Wilkins; 2001:2629-2673.
60. Dittmer D, Mocarski ES: Human cytomegalovirus infection inhibits G1/S transition. J Virol 1997, 71:1629-1634.
61. Jault FM, Jault JM, Ruchti F, Fortunato EA, Clark C, Corbeil J, Richman DD, Spector DH: Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 1995, 69:6697-6704.
62. Balazsi G, Oltvai ZN: Sensing your surroundings: How transcription- regulatory networks of the cell discern environmental signals. Sci STKE 2005, 2005:pe20.
63. DeMeritt IB, Milford LE, Yurochko AD: Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 2004, 78:4498-4507.
64. DeMeritt IB, Podduturi JP, Tilley AM, Nogalski MT, Yurochko AD: Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 2006, 346:15-31.
65. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES: The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 1997, 71:5051-5059.
66. Yurochko AD, Kowalik TF, Huong SM, Huang ES: Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995, 69:5391-5400.
67. He B, Weber GF: Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG. Biochem Biophys Res Commun 2004, 321:13-20.
68. Akira S: IL-6-regulated transcription factors. Int J Biochem Cell Biol 1997, 29:1401-1418.
69. Heinrich PC, Behrmann I, Muller-Newman G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998, 334:297-314.
70. Hirano T: Interleukin-6. In The Cytokine Handbook ed 3 Edited by: A T. New York, Academic Press; 1998:197-228.
71. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS: Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res 2003, 63:2948-2956.
72. Funk CD: Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology. Science 2001, 294:1871-1875.
73. Baneyx G, Baugh L, Vogel V: Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci U S A 2002, 99:5139-5143.
74. Felsenfeld DP: Regulation of complexes by cytoskeletal elements: Integrins serve as force transducers linking mechanical stimuli and biochemical signals. Sci STKE 2005, 2005:tr27.
75. Giancotti FG, Ruoslahti E: Integrin Signaling. Science 1999, 285:1028-1032.
76. Lee B-H, Ruoslahti E: alpha5beta1 Integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/ calmodulin-dependent protein kinase IV. J Cell Biochem 2005, 95:1214-1223.
77. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS: Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002, 8:289-293.
78. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T: Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005, 179(1-2):56-65.
79. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005, 16:1987-2002.
80. Geder L, Lausch R, O'Neill F, Rapp F: Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science 1976, 192:1134-1137.
81. Akintola-Ogunremi O, Luo Q, He TC, Wang HL: Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol 2005, 123:244-249.
82. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS: Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002, 360:1557-1563.
83. Knosel T, Schewe C, Dietel M, Petersen I: Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett 2004, 211:243-247.
84. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM: Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005, 18:838-843.
85. Richardson AK, Cox B, McCredie MRE, Dite GS, Chang J-H, Gertig DM, Southey MC, Giles GG, Hopper JL: Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer 2004, 90:2149-2152.
86. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES: Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A 1999, 96:10881-10886.
87. Manning WC, Stoddart CA, Lagenaur LA, Abenes GB, Mocarski ES: Cytomegalovirus determinant of replication in salivary glands. J Virol 1992, 66:3794-3802.
88. Mayer A, Podlech J, Kurz S, Steffens HP, Maiberger S, Thalmeier K, Angele P, Dreher L, Reddehase MJ: Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol 1997, 71:4589-4598.
89. Chahoud I, Stahlmann R, Bochert G, Dillmann I, Neubert D: Gross-structural defects in rats after acyclovir application on day 10 of gestation. Arch Toxicol 1988, 62:8-14.
90. Klug S, Lewandowski C, Blankenburg G, Merker HJ, Neubert D: Effect of acyclovir on mammalian embryonic development in culture. Arch Toxicol 1985, 58:89-96.
91. Stahlmann R, Klug S, Lewandowski C, Bochert G, Chahoud I, Rahm U, Merker HJ, Neubert D: Prenatal toxicity of acyclovir in rats. Arch Toxicol 1988, 61:468-479.